EGFR
Drug: Erlotinib
Cancer code: UNCLASSIFIED
Cancer type: Burkitt_lymphoma
Drug treatment table
| Cell line ID |
Cell line name |
Mutation in substructure |
IC50(uM) |
| SIDM00793 | EB-3 | A_loop (866) | 27.0913 |
| SIDM00793 | EB-3 | A_loop (866) | 13.4475 |
| SIDM00845 | Daudi | None | 10.4199 |
| SIDM00948 | DG-75 | None | 28.2456 |
| SIDM00863 | EB2 | None | 14.8361 |
| SIDM00808 | JiyoyeP-2003 | None | 13.8196 |
| SIDM00641 | NAMALWA | None | 9.9984 |
| SIDM00844 | Raji | None | 22.7094 |
| SIDM01247 | Ramos-2G6-4C10 | None | 15.2598 |
| SIDM00907 | CA46 | None | 19.6688 |
| SIDM00985 | BL-41 | None | 3.1211 |
| SIDM01198 | ST486 | None | 18.4139 |
| SIDM00854 | GA-10 | None | 0.3109 |
| SIDM00362 | P32-ISH | None | 3.6036 |
| SIDM00845 | Daudi | None | 4.0641 |
| SIDM00948 | DG-75 | None | 16.1603 |
| SIDM00863 | EB2 | None | 6.9561 |
| SIDM00808 | JiyoyeP-2003 | None | 1.3542 |
| SIDM00641 | NAMALWA | None | 7.8827 |
| SIDM00844 | Raji | None | 3.9644 |
| SIDM01247 | Ramos-2G6-4C10 | None | 7.8336 |
| SIDM00907 | CA46 | None | 6.09 |
| SIDM00985 | BL-41 | None | 5.0564 |
| SIDM01198 | ST486 | None | 15.4329 |
| SIDM00854 | GA-10 | None | 3.2933 |
| SIDM00362 | P32-ISH | None | 10.1373 |
